| 发明名称 |
Novel compound for treatment of allergy and asthma |
| 摘要 |
The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma. The invention provides a Fab (antibody fragment), having the following characteristics: a) inhibits the IgE-FcepsiRI interaction; b) binds to free and cell-bound IgE; and c) is non-anaphylactic.
|
| 申请公布号 |
US2003035796(A1) |
申请公布日期 |
2003.02.20 |
| 申请号 |
US20020108301 |
申请日期 |
2002.03.28 |
| 申请人 |
PHARMACIA DEAGNOSTICS AB |
发明人 |
LAFFER SYLVIA;HOGBOM ERIK;ROUX KENNETH H.;ADRIANSSON JONAS;SPERR WOLFGANG R.;VALENT PETER;KRAFT DIETRICH;GRONLUND HANS;VALENTA RUDOLF |
| 分类号 |
C12N15/02;A61K39/395;A61P11/06;A61P37/00;A61P37/08;C07K16/42;C12P21/08;(IPC1-7):A61K39/395;C07K16/44 |
主分类号 |
C12N15/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
